Pacific Biosciences, a US-based gene sequencing company, plans to raise $200m on Nasdaq.
Category: Deals
Watson called in as doctor for Moksha8
Moksha8, a Brazil-based specialty drugs company, raises $61m in its series D round that includes Watson Pharmaceuticals.
Viewdle gazes on larger list of strategic investors
Best Buy Capital and Qualcomm Ventures join BlackBerry Partners Fund in Viewdle’s series B round
BT eyes Tech Mahindra stake sale
Private equity firms reportedly keen on BT’s stake in India’s Tech Mahindra.
Constellation finds stars in CPower deal
Intel and Aster exit portfolio company CPower to Constellation Energy Group.
September hits corporate venturing record
Information technology sector completed twice as many deals as healthcare and media, according to data from Global Corporate Venturing.
Amazon eyes BuyVIP deal
Local news providers said BuyVIP’s sale price could be about $100m if Amazon agrees purchase.
Tonchidot locates three strategic investors
Japan-based phone operator KDDI, advertising company Spire and Itochu Technology Ventures, the corporate venturing unit of industrial group Itochu invested in Tonchidot’s B round
Amyris fuels flotation surge
Flotation price of $16 per share for biofuels company Amyris less than French oil major Total’s purchase of 20% of the company in July.
Ongo gains $12m seed round
Three US publishers provide strategic investment in Ongo, a start-up company expected to launch a consumer service for reading and sharing digital news and information.
Novo backs Tobira Therapeutics
Tobira Therapeutics raises $31m in its series B round.
Glo lights up Nordic venture
Corporate venturing units Hafslund Venture and Agder Energi Venture back Glo, a Sweden-based developer of lights.
Roche discovered over Horizon deal
Roche Venture Fund has reinvested in Horizon Discovery’s third round of funding.
Cylene extends C round to three years
Eli Lilly and Novartis back Cylene’s latest $12m funding in a round reportedly extended more than three years.